ATRC
AtriCure, Inc.
Nasdaq · usd
AtriCure, Inc. (ATRC) trades at $55.02 (-0.52%) as of 7:31:45 PM EST on Nov 17, 2026, -0.92% over the past month. Market cap is $2.82B, with 7.6 days to cover in short interest.
Stock performance
How AtriCure, Inc. (ATRC) stock has performed from one day to one year, with its 52-week range.
- 1D
- -0.52%
- 1W
- -2.20%
- 1M
- -0.92%
- YTD
- +39.08%
- 1Y
- +65.92%
- 52-wk range
- $25.36 – $66.02
Key statistics
Today's trading snapshot for ATRC: day range, open, previous close, volume and market cap.
- Day range
- $53.88 – $55.98
- Open
- $55.32
- Prev close
- $55.31
- Volume
- 663.59K
- Market cap
- $2.82B
- Shares out
- 50.92M
Valuation and profitability ratios: P/E, P/S, ROE
Valuation and profitability ratios for AtriCure, Inc.: P/E, P/S, P/B, ROE and more.
- P/E
- 189.24
- P/S
- 4.78
- P/B
- 5.28
- P/FCF
- 53.20
- ROE
- 2.8%
- ROA
- 2.1%
- Debt/Equity
- 0.11
- Div yield
- 0.00%
As of Nov 16, 2026
8-K filings
Material corporate events AtriCure, Inc. has disclosed to the SEC on Form 8-K.
- Quarterly earningsNov 3, 2026
On November 3, 2026, AtriCure, Inc. issued a press release regarding its financial results for the third quarter ended September 30, 2026.
- Annual meeting resultsMay 19, 2026
The stockholders of the Company voted on the following proposals at the Annual Meeting: 1. The election of nine directors to serve one-year terms expiring at the 2027 Annual Meeting of Stockholders... All nominees for director were duly elected to serve one-year terms expiring at the 2027 Annual Meeting of Stockholders and until their successors have been duly elected and qualified.
- Credit facilityJan 12, 2026
On January 9, 2026, AtriCure, Inc. and its wholly owned subsidiary, AtriCure, LLC, entered into a First Amendment to Credit Agreement among the Borrowers, JPMorgan Chase Bank, N.A., as administrative agent, and the lenders party thereto. The First Amendment provides for a three year extension of the term of the Credit Agreement. The First Amendment also provides for a reduction in the overall interest rate on the loans under the ABL Facility and removes the minimum utilization financial covenant in addition to certain other loan administration updates.
- Annual meeting resultsMay 20, 2025
The stockholders of the Company voted on the following proposals at the Annual Meeting: 1. The election of nine directors to serve one-year terms expiring at the 2026 Annual Meeting of Stockholders... Each nominee for director was duty elected to serve one-year terms expiring at the 2026 Annual Meeting of Stockholders and until their successors have been duly elected and qualified.
- Investor presentationMar 26, 2025
On March 26, 2025, AtriCure, Inc. (the "Company") is conducting its previously announced 2025 Investor Day presentation from approximately 1:00 p.m. to 4:00 p.m. Eastern Time, at the Company's headquarters in Mason, Ohio which was simultaneously broadcast via webcast. A copy of the 2025 Investor Day presentation is furnished as Exhibit 99.1 to this Form 8-K.
ATRC short interest
How heavily ATRC is shorted: shares short, days to cover and average daily volume.
- Days to cover
- 7.6
- Short interest
- 4.89M
- Avg volume
- 643.49K
As of · reported to FINRA twice monthly.
ATRC news
The latest news and headlines about AtriCure, Inc. (ATRC).
- Atrial Fibrillation Treatment Devices Market Trends and Forecast, 2035 | Includes Profiles of Abbott, AtriCure, Boston Scientific, Johnson & Johnson, and MedtronicpositiveGlobeNewswire Inc.· Aug 26, 2026
- Two AtriCure Directors Trimmed Shares After a Strong Quarter. Here's What Matters for InvestorspositiveThe Motley Fool· Aug 7, 2026
- Is AtriCure Stock a Buy or Sell After a Director Dumped 10,000 Shares?neutralThe Motley Fool· Nov 29, 2025
- Questex’s Fierce Healthcare Announces 2025 Fierce DEI Award FinalistspositiveGlobeNewswire Inc.· May 14, 2025
- AtriCure gains China's nod for heart surgery device - Investing.compositiveInvesting.com· Jul 23, 2024
Frequently asked questions
What is the AtriCure, Inc. (ATRC) stock price today?
AtriCure, Inc. (ATRC) is trading at $55.02 (-0.52% on the day) as of 7:31:45 PM EST on Nov 17, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.
What is AtriCure, Inc.?
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors.
What is the short interest in ATRC?
As of Oct 30, 2026, ATRC has 4.89M shares short and 7.6 days to cover.
What exchange is ATRC listed on?
AtriCure, Inc. (ATRC) trades on Nasdaq in USD, in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry.
Build with AI
Build an analysis of ATRC with your agent
Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.
Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a ATRC analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.